Biological Activity of a Novel Nonpeptide Antagonist to the Interleukin-6 Receptor 20S,21-Epoxy-resibufogenin-3-formate-Reference-Cited by-同舟云学术

Biological Activity of a Novel Nonpeptide Antagonist to the Interleukin-6 Receptor 20S,21-Epoxy-resibufogenin-3-formate

Published:2002-10-01 Issue:1 Volume:303 Page:104-109
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Hayashi Masahiko,Rho Mun-Chual,Fukami Akiko,Enomoto Akiko,Nonaka Shinobu,Sekiguchi Yoshino,Yanagisawa Tadashi,Yamashita Ayano,Nogawa Toshihiko,Kamano Yoshiaki,Komiyama Kanki

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference42 articles.

1. Biology of multifunctional cytokines: IL-6 and related molecules (IL-1 and TNF).;Akira;FASEB J,1990

2. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.;Carmichael;Cancer Res,1987

3. LIFRβ and gp130 as Heterodimerizing Signal Transducers of the Tripartite CNTF Receptor

4. Preparation and characterization of plasma membrane vesicles from human polymorphonuclear leukocytes

5. Developmental regulation of expression of C-reactive protein and serum amyloid A in Syrian hamsters.;Dowton;Pediatr Res,1991

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of IL-6 in Cancer Cell Invasiveness and Metastasis—Overview and Therapeutic Opportunities;Cells;2022-11-21

2. Evaluation of the Tocilizumab therapy in human cancers: Latest evidence and clinical potential;Journal of Clinical Pharmacy and Therapeutics;2022-10-21

3. New-Generation Heterocyclic Bis-Pentamethinium Salts as Potential Cytostatic Drugs with Dual IL-6R and Mitochondria-Targeting Activity;Pharmaceutics;2022-08-17

4. Small molecule approaches to treat autoimmune and inflammatory diseases (Part III): Targeting cytokines and cytokine receptor complexes;Bioorganic & Medicinal Chemistry Letters;2021-09

5. Targeting SOCS Proteins to Control JAK-STAT Signalling in Disease;Trends in Pharmacological Sciences;2019-05